Evidence map›Paper›PMID 39747901›Full record

ArticleScientific reports2025

L-Aspartic acid-functionalized magnetic nanoparticles: as a new magnetically reusable bifunctional acid-base catalysts for the synthesis of benzo[b]pyran and pyrano[3,2-c] chromene derivatives.

Leila Amiri-Zirtol, Hanieh Mostashfi, Razieh Sabet, Zahra Karimi, Reza Ranjbar-Karimi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. A dendritic nanocatalyst (FeScientific reports · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leila Amiri-ZirtolPharmaceutical Science Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Hanieh MostashfiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Razieh SabetDepartment of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. sabet_r@sums.ac.ir.
Zahra KarimiSchool of Chemical, Petroleum and Gas Engineering, Iran University of Science and Technology (IUST), Tehran, Iran.
Reza Ranjbar-KarimiDepartment of Chemistry, Vali-e-Asr University of Rafsanjan, Rafsanjan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

"Green chemistry" describes the development of new technologies that reduce or eliminate the need for hazardous compounds or the production of them. In order to accomplish this goal, we have developed a new magnetic recyclable biocatalyst in this study by successfully applying aspartic acid to magnetic nanoparticles. Aspartic acid's molecular makeup made it possible for it to stabilize on magnetic nanoparticles using a straightforward method. We characterized the synthesized catalyst using microscopic and spectroscopic techniques such as Fourier transform infrared (FT-IR), X-ray diffraction (XRD), Field emission scanning electron microscopy (FE-SEM), Energy-dispersive X-ray spectroscopy (EDS), vibrating sample magnetometer (VSM) and transmission electron microscopy (TEM). The catalytic activity of this organocatalyst was evaluated for the synthesis of benzo[b]pyran and pyrano[3,2-c] chromene derivatives, exhibiting excellent efficiency. This protocol offers several benefits, such as using a low-cost biocatalyst, nontoxicity, high product yield, easy separation, short reaction times, catalyst reusability, and H

Indexed as

BiocatalystGreen chemistryMagneticOrganocatalyst

Identifiers

PMID39747901
PMCPMC11697017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.